About Shockwave Medical

Now a part of Johnson & Johnson MedTech

Same Shock, Bigger Waves

At Shockwave, innovation is in our DNA. We never settle for the status quo and are constantly pioneering ways to address unmet clinical needs with low-risk treatment options for underserved patient populations suffering from cardiovascular disease. From Intravascular Lithotripsy (IVL) to Coronary Sinus Reduction and beyond, our technologies transform lives around the world.

As part of Johnson & Johnson MedTech, we’ll continue to deliver our same unmatched commitment to innovation, customer service and improving patient outcomes. In fact, the added strength of the global leader in healthcare energizes our ability to make even bigger waves – and the future looks shockingly bright.

Chalk, Organic Eggs & Cadaver Legs: IVL's Journey from Idea to Reality

Chalk, Organic Eggs & Cadaver Legs

In 2009, a marketer, engineer and cardiologist came together to change the nature of interventional therapy for calcified cardiovascular disease. They envisioned a future in which lithotripsy, a trusted technology used to break kidney stones, could be adapted to crack calcified lesions in a safe and easy manner. What started out as a crazy idea has changed the standard of care for patients with cardiovascular disease around the globe.   

Awards

Thinking Forward. Moving Ahead.